After being kept out of the public conscience for the best part of a century, cannabis is back in the mainstream conversation, with strong scientific arguments for the plant’s use as a medicine convincing medical experts and politicians alike.
We have seen the emergence of cannabidiol (CBD), a non-psychoactive derivative of the herb that has potent medical properties, and crucially, even when administered as an isolated compound. This non-intoxicating version of cannabis comes in the form of CBD oil, CBD edibles, CBD vape oil and more.CBD vape oil and e-liquid
Not only is it safe, but with CBD possible to consume without it having to be smoked in a pipe or joint, it’s a more viable treatment for patients, particularly seniors and children. Furthermore, CBD doesn’t cause any hallucinogenic effects or any other significant side effects.
However, it wasn’t until the 1990s that researchers started to recognize just how influential CBD could be for the body, and as a treatment for multiple conditions. The endocannabinoid system (ECS) was found after the discovery of anandamide by Raphael Mechoulam, who in 1964 isolated tetrahydrocannabinol (THC) from the rest of the plant for the first time.
Mechoulam noted that THC and anandamide had many similarities and had actually been in search for a compound in the body that worked similarly to THC.
The cannabis plant contains 113 cannabinoids – CBD and THC are two of them. Most have not been researched thoroughly, although we have an ever-improving understanding of cannabigerol (CBG), cannabichromene (CBC), cannabidivarin (CBDV), cannabinol (CBN) and more. These non-psychoactive cannabinoids are normally found in much lower concentrations but possess some notable medical benefits. CBD gummy bears.
CBG’s anti-bacterial and antimicrobial properties could make it an effective tool for preserving oral health.
CBC’s neuroprotective and neurogenesis effects could help to protect the hippocampus, and even restore it – brain scans have shown that depression causes the hippocampus to shrink, with this neurodegeneration potentially causing memory issues.
Meanwhile, CBDV has potent anti-nausea properties, which may be of benefit to chemotherapy patients – the treatment tends to cause nausea, vomiting and chronic pain, among other issues.
Growth of hemp-based CBD.
The 2014 Farm Bill has opened the door for hemp-based CBD products, which can be purchased throughout the nation. These products are made with extracts from the hemp plant – the leading companies choose supercritical CO2 extraction to guarantee the safety and quality of the oil.
With no regulation from the Food & Drug Adminstration (FDA), the CBD industry has been left to find its feet and build up trust levels with customers. That’s why many manufacturers hire a third party, so their products can be tested objectively in laboratory conditions to authenticate claims made on the packaging .
There has been much debate by cannabis researchers about the importance of whole-plant medicine. Many, and this is now the prevailing argument, suggest that cannabinoids are more effective when taken together, than when administered in isolated fashion – this theory of synergy is known as the “entourage effect.” Therefore, it’s no surprise that full-spectrum CBD products are very popular, as customers seek to derive the benefits of the plant’s other cannabinoids and terpenes. However, even a whole-plant hemp extract is only going to contain traces of THC. The Farm Bill makes no mention of CBD or other cannabis compounds, with its only restriction being THC at 0.3 percent.
Interest in vaping has soared massively in recent times, for health reasons more than anything. Vapor is nowhere near as dangerous to inhale as smoke, and does not coat the lungs in tar, nor does it expose the body to harmful toxins, carcinogens and other noxious substance. CBD vape oil and e-liquid is sold in a variety of flavors and potencies, to help with acute pain, anxiety and more.CBD edibles.
CBD creams have the potential to slow ageing, to manage skin complaints like psoriasis and to treat inflammation and pain. The interactions that cannabinoids in these topicals makes with the cannabinoid receptors in the skin are wide-ranging. CBD can adjust immune system response to stop the proliferation of new skin cells on the surface of the skin, and also regulate the amount of sebum produced by sebaceous glands.
The super-strength concentrate market has also grown among medicinal and recreational users, who favor CBD-isolate and THC-isolate products respectively.
The future for recreational cannabis
The rise of medical cannabis is bringing about a more receptive attitude to the plant generally, hence the surge in support for recreational cannabis legalization – nowhere is this more apparent than the United States. According to Pew Research, support for recreational marijuana has doubled since the turn of millennium, standing at 61 percent in September 2017.
And while states like California and Colorado have gotten than further than more conservative states such as Alabama and Utah, support for cannabis is growing everywhere. States that haven’t yet legalized recreational marijuana mostly have advanced medical programs or permit CBD use.CBD vape oil and e-liquid.
The federal government has opted against making the swifter changes we’re seeing at state level, but a rescheduling of cannabis – or at least CBD – looks likely to happen in the near future, following the approval of Epidiolex by the FDA, an epilepsy treatment made using a CBD extract.
With the opioid crisis claiming tens of thousands of lives annually, the potential of cannabis as a painkiller and treatment for addiction cannot be ignored.
After being banned in most countries during the first half of the 20th century, cannabis is now enjoying a mighty renaissance. Several states in the US have showed what’s possible with medical cannabis, while Amsterdam in the Netherlands remains a hub for recreational smokers – the Dutch decriminalized marijuana, with law enforcement turning a blind eye to possession up to 5 grams.
Now, Canada has become the first country in the G7 to legalize cannabis nationwide. Meanwhile, the United Kingdom has just announced that medical cannabis will be available for certain patients from autumn 2018. Many other European countries are enjoying high-CBD cannabis, in oil form and in cannabis cigarettes.